LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
AIM AIM ImmunoTech
- 0.2083
- +0.0073+3.63%
Close Dec 27 16:00 ET
- 0.2040
- -0.0043-2.06%
Post 19:34 ET
13.29MMarket Cap-0.44P/E (TTM)
0.2100High0.1950Low747.92KVolume0.1950Open0.2010Pre Close150.84KTurnover1.33%Turnover RatioLossP/E (Static)63.78MShares0.620052wk High4.53P/B11.73MFloat Cap0.162852wk Low--Dividend TTM56.31MShs Float836.0000Historical High--Div YieldTTM7.46%Amplitude0.1628Historical Low0.2010Avg Price1Lot Size
AIM ImmunoTech Key Stats
EPS
According to the latest financial report of AIM ImmunoTech, the latest earnings per share (TTM) for the company is -0.06. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about AIM ImmunoTech's free cash flow? The latest report shows it as -3.27M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of AIM ImmunoTech shows that the company's current ratio is 0.75, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of AIM ImmunoTech, the quick ratio is 0.71, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of AIM ImmunoTech? The latest ROE figure is -82.09%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of AIM ImmunoTech, the total asset return on investment (ROA) is -25.25%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check AIM ImmunoTech's latest financial report to see how their gross margin is doing - currently at 77.14%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of AIM ImmunoTech, the net profit margin is -10.57K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...